OPSEU Pension Plan Trust Fund’s Vertex Pharmaceuticals VRTX Stock Holding History

OPSEU Pension Plan Trust Fund’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8,500	Closed	-$2.51M	–	275
2022 Q3	$2.51M	Buy	8,500 +62	+0.7%	+$17.8K	0.66%	21
2022 Q2	$2.36M	Buy	8,438 +3,119	+59%	+$835K	0.59%	30
2022 Q1	$1.39M	Buy	5,319 +185	+4%	+$43.9K	0.33%	135
2021 Q4	$1.14M	Buy	5,134 +20	+0.4%	+$3.89K	0.26%	169
2021 Q3	$921K	Sell	5,114 -130	-2%	-$25.4K	0.23%	182
2021 Q2	$1.06M	Buy	+5,244	New	+$1.1M	0.27%	171

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

OPSEU Pension Plan Trust Fund's VRTX Position: Q4 2022 in Review

OPSEU Pension Plan Trust Fund sold out of Vertex Pharmaceuticals (VRTX) in Q4 2022, closing a stake of 8,500 shares — an estimated $2.51M sold.

OPSEU Pension Plan Trust Fund first reported a position in VRTX in Q2 2021 and held it in 6 quarters. The position peaked at $2.51M in Q3 2022. 1,222 funds tracked by Wall St. Rank hold VRTX as of Q4 2022.

OPSEU Pension Plan Trust Fund reported no remaining Vertex Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
OPSEU Pension Plan Trust Fund sold 8,500 Vertex Pharmaceuticals shares in Q4 2022, an estimated $2.51M.
OPSEU Pension Plan Trust Fund first reported a position in Vertex Pharmaceuticals in Q2 2021 and held it in 6 quarters.
OPSEU Pension Plan Trust Fund's Vertex Pharmaceuticals position peaked at $2.51M in Q3 2022.
1,222 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2022.

Based on OPSEU Pension Plan Trust Fund's 13F filing for Q4 2022, filed 9 Feb 2023.